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Abstract
Objective: To review evidence on the associations between vitamin B12 intake
and its biomarkers, vitamin B12 intake and its functional health outcomes, and
vitamin B12 biomarkers and functional health outcomes.
Design: A systematic review was conducted by searching electronic databases,
until January 2012, using a standardized strategy developed in the EURRECA
network. Relevant articles were screened and sorted based on title and abstract,
then based on full text, and finally included if they met inclusion criteria. A total
of sixteen articles were included in the review.
Setting: Articles covered four continents: America (n 4), Europe (n 8), Africa (n 1)
and Asia (n 3).
Subjects: Population groups included healthy infants, children and adolescents,
and pregnant and lactating women.
Results: From the total number of 5815 papers retrieved from the initial search,
only sixteen were eligible according to the inclusion criteria: five for infants, five
for children and adolescents, and six for pregnant and lactating women.
Conclusions: Only one main conclusion could be extracted from this scarce
number of references: a positive association between vitamin B12 intake and
serum vitamin B12 in the infant group. Other associations were not reported in
the eligible papers or the results were not provided in a consistent manner.
The low number of papers that could be included in our systematic review is
probably due to the attention that is currently given to research on vitamin B12 in
elderly people. Our observations in the current systematic review justify the idea
of performing well-designed studies on vitamin B12 in young populations.
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Nutrition plays an important role in the programming of
health across the lifespan, especially during the earliest
periods, because of short- and long-term consequences
in the absence of appropriate nutrition(1). There are bio-
logical substances which keep homeostasis to prevent
adverse health outcomes like vitamin B12. In recent years,
only a few studies have focused on the relationship
between low vitamin B12 intake and cognitive function,
megaloblastic anaemia or growth in young populations.
Across Europe, current reference values for vitamin B12
intake vary for infants from 0?3–0?5 to 1?5mg/d depending
on whether they are 3 or 9 months old, respectively(2),
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from 0?8 to 3?0mg/d for children and adolescents(3) and
from 1?5 to 4?0mg/d for pregnant and lactating women(4,5).
The range of ages, values and terminology used for
recommendations differ between European countries.
However, the underlying concepts could be equivalent to:
the RDA (Recommended Dietary Allowance, which is the
daily dietary intake level of a nutrient considered sufficient
to meet the requirements of nearly all (97–98%) healthy
individuals in each life stage and gender group), the
AI (Adequate Intake, which is an estimation of the lowest
intake level that seems sufficient for almost all people in a
group) and the acceptable range (which is defined as the
range of intakes high enough to avoid deficiency and low
enough to avoid toxic effects). For vulnerable population
groups such as those represented herein, nutrient require-
ments are generally obtained from data extrapolated from
the adult ANR (Average Nutrient Requirement, which is
the estimated average or median requirement of a specific
nutrient in a population)(6).
In Western countries, the dietary intake of vitamin B12
among children, adolescents and adults is usually higher
than the average requirement for vitamin B12. For instance,
the Spanish study EnKid showed that the 2–24-year-old
population had a mean daily vitamin B12 intake of 8?2mg
(males) and 6?8mg (females)(7). However, data from the
Framingham Offspring Study suggest that suboptimal
vitamin B12 status occurs at intakes exceeding the recom-
mended intakes(8) and raise the question of whether the
current recommended intakes for vitamin B12 are adequate
to promote a normal vitamin B12 status
(9) and influence the
occurrence of several health outcomes(8,10–12).
The preferred approach to define the requirement
takes into account the level of intake at which functioning
is optimal. This implies that both preventing deficiencies
as well as reducing the risk of developing other chronic
disorders have to be taken into account(13,14).
In order to provide up-to-date and evidence-based
micronutrient reference values across Europe, it is impor-
tant to assess the micronutrient status for different popu-
lation groups(15) through its preferred biomarkers or
functional health outcomes(16). The use of a biomarker that
reflects changes in micronutrient status can facilitate the
understanding of the relationships between dietary micro-
nutrient intake and status or health outcomes (Fig. 1). The
best tools to provide this information are dose–response
and repletion–depletion studies, but they are rarely
carried out.
The aim of the present paper is to systematically
review dose–response evidence from randomized con-
trolled trials (RCT), prospective cohort and cross-sectional
studies on the association of vitamin B12 with its main
biomarkers, and also with its main health outcomes in
infants, children, adolescents and pregnant and lactating
women. The ultimate goal would be to provide micro-
nutrient reference intake values for vitamin B12 in the
aforementioned population groups.
Methods
The current systematic review on vitamin B12 in young
populations and pregnant and lactating women was per-
formed within the framework of EURRECA (www.eurreca.
org) and has focused on one of the prioritized relationships
set by the network(17) as illustrated in Fig. 1.
Search methods for identification of studies
To find the search strategy terms and the criteria for
exclusion/inclusion papers, data on vitamin B12
(17) were
first reviewed. A multiple-database searching in MEDLINE,
Embase (both on Ovid) and the Cochrane Library CENTRAL
was carried out until 17 February 2009. The general search
strategy included terms on study designs in humans AND
(intake or status) AND (vitamin B12). The search terms
included both MeSH terms and words to be found in the
title or abstract. The initial search yielded 5815 references
after exclusion of duplicates. Reference lists of six relevant
review articles(18–23) were checked also to identify poten-
tially relevant references that were not yet collected. This
search did not yield any other references.
In January 2012 the search was repeated to retrieve
other possible relevant papers. This search retrieved
596 new papers.
Criteria for the consideration of studies
Studies had to fulfill the following criteria to be included
in the review:
1. Investigate the possible relationships between vitamin
B12 intake, its biomarker levels or the selected health
outcomes, following the structure available in Fig. 1;
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1
2
Intake
(exposure)
Status
(indicators of exposure
or body stores)
Health
(functional or clinical
outcomes)
3
Fig. 1 Intake–status–health relationships relevant for deriving reference values: 15 intake–health relationship; 25 intake–status
relationship; 35 status–health relationship
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2. Provide vitamin B12 from supplements, fortified foods
or natural dietary sources;
3. Be observational studies (prospective cohort, nested
case–control or cross-sectional, the latter for intake–status
associations only) or intervention studies (only RCT);
4. Be performed in human subjects from birth to 18 years
or pregnant or lactating women;
5. Include apparently healthy subjects.
Results on adults and the elderly in studying these
relationships are reported elsewhere.
Accepted dietary assessment methods to include the
paper were: (i) validated FFQ/dietary history; and (ii) 24 h
recall/food records/diary measures for at least 2 d.
Serum/plasma vitamin B12, methylmalonic acid (MMA)
and holotranscobalamin (HoloTC)(24) were the biomarkers
included as the most robust and sensitive biomarkers
identified through earlier research activities in the EURRECA
network(25,26).
The health outcomes chosen were those most relevant
for the population group (based on public health reports
and the scientific literature, i.e. current evidence of a
relationship and the number of preliminary search hits
from online databases) and not recently and thoroughly
covered by a similar review. Health outcomes differed
between population groups:
1. Neurodevelopment and megaloblastic anaemia for
infants;
2. Megaloblastic anaemia, growth and cognitive function
for children and adolescents;
3. Fetal malformations and fetal growth for fetuses;
4. Megaloblastic anaemia and pre-eclampsia for mothers.
Collection of papers
The results of the searches were combined in EndNote
XII (Thompson Reuters). References were screened
based on title and abstract. They were then sorted by
population group: (i) infants, (ii) children and adole-
scents and (iii) pregnant and lactating women; and by
relationship following the analytical model: (i) intake–
health (I-H), (ii) intake–status (I-S), (iii) status–health
(S-H) and (iv) intake–status–health (I-S-H).
Selection of studies
Once papers were screened based on title and abstract
and sorted by population group, those selected were again
screened based on full text by obtaining them electro-
nically, as photocopies or reprints, according to the pre-
defined criteria. The reasons for exclusion and the name of
the reviewer were registered in the EndNote library. One
hundred and seventeen potentially relevant references
were considered for inclusion based on full text review;
characteristics of the 101 references excluded are shown in
Table 1. Figure 2 shows the flowchart of the selection steps
for the populations reviewed herein. If language expertise
existed in the review team, articles written in languages
other than English could be included.
Data extraction
Data from papers identified as relevant were extracted
to characterize studies and to facilitate meta-analysis.
Data were entered into an Access database specifically
developed for EURRECA.
Quality check controls
For alignment and quality control, at the start of each step
two independent reviewers screened 10% of the references
in duplicate. Any discrepancies at this step were discussed
before proceeding with the rest of the references.
Assessment of risk of bias in included studies
To exclude major sources of bias, internal validity of the
relevant studies was assessed. The criteria used were
adapted from the Cochrane Handbook(27). The criteria
for RCT were based on: method of sequence generation
and allocation; blinding; potential funding bias; number of
participants at start; drop-outs and reasons for dropping
out; dose check; dietary intake data reported; and similarity
of most and least exposed groups at baseline. For longi-
tudinal studies the criteria were based on: drop-outs
adequate and outcome data complete; funding; lack of
other potential threats to validity; control for confounders;
and assessment of exposure adequacy. For cross-sectional
studies the criteria were based on: funding; lack of other
potential threats to validity, such as those related to the
specific study design used or related to differences in
baseline characteristics of participants; confounders; and
assessment of exposure adequacy.
Results
The systematic search retrieved sixteen relevant papers.
Table 2 summarizes the characteristics and results of these
studies.
Infants
Two out of five selected papers were RCT(28,29) and three
were observational studies (one cross-sectional(30) and two
longitudinal studies(31,32)). In all these studies the association
between intake and status (I-S) was reported, except for
one longitudinal study(32). In both RCT, the intervention
groups(28,29) received vitamin B12 through intramuscular
injection: once per month during the first 4 months
(100mg/month) in one study(29) and in the other(28) the
injected amount was only once (400mg). In the RCT from
Worthington-White et al.(29), serum levels were significantly
increased after the intervention (either with or without folate
supplementation) at each point of the measurements. In that
study, the dose–response association between injected
vitamin B12 and levels of biomarkers was not estimated.
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Table 1 Characteristics of excluded studies
Reference Main reason for exclusion
Monsen et al. (2003)(58) Only data on biomarkers
Monsen et al. (2006)(59) Does not address any relationships of interest
Casanueva et al. (2006)(60) Type of intervention: multivitamin supplement
Choudhry et al. (1972)(61) Study design: intervention but not RCT
Cikot et al. (2001)(62) Only data on biomarkers
Couto et al. (2007)(63) Only data on biomarkers
Cornel et al. (2005)(64) Irrelevant micronutrient
Czeizel and Dudas (1992)(65) Type of intervention: multi-vitamin supplement
Czeizel and Medveczky (2003)(66) Does not address any relationships of interest
Dagnelie et al. (1989)(67) Does not address any relationships of interest
Dawson et al. (2000)(68) Study design: intervention but not RCT
van Dusseldorp et al. (1999)(69) Study design: case–control study
Eilander et al. (2010)(70) Study design: cross-sectional study investigating S-H relationship
Gomber et al. (2003)(71) Study design: cross-sectional study investigating S-H relationship
Gomber et al. (1998)(72) Study design: cross-sectional study investigating S-H relationship
Gordon and Carson (1976)(73) Study design: case report
Graham et al. (1992)(74) Population group: infants did not meet the inclusion criteria (unhealthy)
Haggarty et al. (2006)(75) Irrelevant health outcome
Haiden et al. (2006)(76) Type of intervention: multi-vitamin supplement
Haiden et al. (2006)(77) Type of intervention: multi-vitamin supplement
Hay et al. (2010)(78) Relationship assessed: S-S
Hininger et al. (2004)(79) Type of intervention: multi-vitamin supplement
Hjelt and Krasilnikoff (1990)(80) Population group: infants did not meet the inclusion criteria (unhealthy)
Huemer et al. (2005)(81) Study design: case report
Ja¨rvenpa¨a¨ et al. (2007)(82) Does not address any relationships of interest
Johnson et al. (2002)(83) Does not address any relationships of interest
Knight et al. (1994)(84) Only data on biomarkers
Kuschel and Harding (2004)(19) Study design: systematic review
Levy et al. (1992)(85) Type of intervention: multi-vitamin supplement
Lo´pez de Roman˜a et al. (2005)(86) Type of intervention: multi-vitamin supplement
Lovblad et al. (1997)(87) Irrelevant health outcome
Lundgren and Blennow (1999)(88) Study design: case report
Makedos et al. (2007)(89) Study design: case–control
Mamlok et al. (1986)(90) Study design: case report
Martin et al. (2004)(91) Does not address any relationships of interest
Mathan et al. (1979)(92) Does not address any relationships of interest
Mathews (1996)(20) Does not address any relationships of interest
Maurage et al. (1995)(93) Does not address any relationships of interest
Masalha et al. (2008)(94) Study design: cross-sectional study investigating I-H relationship
McCoy et al. (1984)(95) Only data on intakes
McGrath et al. (2006)(96) Population group: mothers did not meet the inclusion criteria (unhealthy)
McNulty et al. (1996)(97) Only data on intakes
Mena et al. (2001)(98) Irrelevant health outcome
Merialdi et al. (2004)(99) Does not address any relationships of interest
Metcalf et al. (1994)(100) Does not address any relationships of interest
Metz et al. (1965)(101) Study design: intervention but not RCT
Mills et al. (2005)(102) Type of intervention: multi-vitamin supplement
Minet et al. (2000)(103) Does not address any relationships of interest
Miyake et al. (2006)(104) Irrelevant health outcome
Molloy et al. (1985)(105) Irrelevant health outcome
Molloy et al. (2005)(106) Study design: cross-sectional study investigating S-H relationship
Monagle and Tauro (1997)(107) Study design: description of several cases
Moran (2007)(108) Only data on biomarkers
Morkbak et al. (2007)(109) Study design: editor letter
Msolla and Kinabo (1997)(110) Irrelevant biomarkers
Murphy et al. (2007)(111) Study design: S-S
Mwanda and Dave (1999)(112) Study design: intervention but not RCT
Neiger et al. (1993)(113) Population group: mothers did not meet the inclusion criteria (unhealthy)
Nelen et al. (2000)(114) Does not address any relationships of interest
Neri et al. (2005)(115) Irrelevant health outcome
Neuhouser et al. (1998)(116) Does not address any relationships of interest
Neumann and Harrison (1994)(117) Irrelevant health outcome
Niebyl and Goodwin (2002)(118) Irrelevant health outcome
Nikolaus and Nikolaus (1979)(119) Study design: intervention but not RCT
Osganian et al. (1999)(120) Only data on biomarkers
Patel and Lovelady (1998)(121) Study design: intervention but not RCT
Ratan et al. (2008)(122) Does not address any relationships of interest
Ray and Laskin (1999)(23) Does not address any relationships of interest
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In the RCT from Bjorke-Monsen et al.(28), the intervention
was the strongest predictor of changes for all blood indices
(regression coefficient5183 for serum vitamin B12 and
regression coefficient520?70 for MMA). Four months
after delivery, the median (range) of serum vitamin B12
was 421 (291–497) pmol/l and 240 (162–337) pmol/l for
the intervention and placebo groups, respectively; corres-
ponding values for MMA were 0?2 (0?15–0?43) pmol/l and
0?51 (0?23–1?55) pmol/l.
In the Guatemalan cross-sectional study(30), mean intake
of vitamin B12 was 3?1mg/d for mothers and 2?2mg/d for
infants at the age of 12 months and the accompanying
mean (SD) plasma vitamin B12 concentration in mothers
and infants was 114?4 (9?2) g/l and 262?2 (163?5) pmol/l,
respectively. The plasma vitamin B12 concentrations of the
infants were correlated with maternal concentrations and
they were also positively associated with infant B12 intake
from complementary foods (r5 0?16, P, 0?0001).
In the longitudinal study by Hay et al.(31), the results were
divided between breast-fed (n 104) and non-breast-fed
(n 115) infants: the mean intake of vitamin B12 was 1?4
(95% CI 1?3, 1?6)mg/d for breast-fed infants excluding the
intake from breast milk and 2?4 (95% CI 2?1, 2?6)mg/d for
the non-breast-fed infants. In that study, the selected
biomarkers were measured at the age of 12 months. Mean
(95% CI) serum vitamin B12, HoloTC and MMA were 343
(319, 369) pmol/l, 54 (49, 60) pmol/l and 0?22 (0?20, 0?25)
mmol/l, respectively, for breast-fed infants, and 397 (372,
424) pmol/l, 76 (70, 83) pmol/l and 0?20 (0?19, 0?22)
mmol/l, respectively, for non-breast-fed infants. Infants
who were breast-fed at the age of 12 months had sig-
nificantly lower serum vitamin B12 and HoloTC and
higher MMA than those who were not breast-fed at the
same age. In that study, total vitamin B12 intake from
complementary foods was positively associated with
serum vitamin B12 (r5 0?15 and P5 0?030) and HoloTC
(r5 0?25 and P5 0?001).
The longitudinal study by Dagnelie et al.(32) was the only
one studying the relationship between vitamin B12 intake
and health, specifically psychomotor development, in spite
of the status also being stated in the paper. However, they
were not related with intakes or health outcomes. The
results were divided between infants following a specified
macrobiotic diet and those following an omnivorous one.
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Table 1 Continued
Reference Main reason for exclusion
Ray and Blom (2003)(53) Irrelevant health outcome
Ronnenberg et al. (2000)(123) Irrelevant population group
Ronnenberg et al. (2002)(124) Irrelevant biomarkers
Ronnenberg et al. (2002)(125) Study design: case–control
Ronnenberg et al. (2007)(126) Does not address any relationships of interest
Rumbold et al. (2005)(127) Type of intervention: multi-vitamin supplement
Sachdeva and Mann (1994)(128) Does not address any relationships of interest
Scatliff et al. (2011)(129) Population group: children did not meet the inclusion criteria (unhealthy)
Schneede et al. (1994)(130) Only data on biomarkers
Shih et al. (1976)(131) Study design: editor letter
Siekmann et al. (2003)(132) The intervention was realized with meat or milk
Singla et al. (1982)(133) Type of intervention: multi-vitamin supplement
Sivakumar et al. (2006)(134) Only data on biomarkers
Smith Fawzi et al. (2007)(135) Irrelevant health outcome
Sneed et al. (1981)(136) Study design: intervention but not RCT
Sohrabvand et al. (2006)(137) Irrelevant health outcome
Steegers-Theunissen et al. (1995)(138) Does not address any relationships of interest
Steen et al. (1998)(139) Irrelevant health outcome
Strand et al. (2007)(140) Does not address any relationships of interest
Suarez et al. (2003)(141) Irrelevant health outcome
Thomas et al. (2008)(142) Does not address any relationships of interest
Thompson et al. (2009)(143) Irrelevant health outcome
Thoradeniya et al. (2006)(144) Only data on biomarkers
Thurlow et al. (2005)(145) Study design: cross-sectional study investigating S-H relationship
Valman (1972)(146) Study design: case report
Veena et al. (2010)(147) Study design: maternal S and children’s H at 10 years old
Verkleij-Hagoort et al. (2008)(148) Study design: case–control
Villamor et al. (2008)(149) Study design: data from I is referred to dietary patterns, not to proper
amounts of micronutrient
Vinod Kumar and Rajagopalan (2008)(150) Type of intervention: multi-vitamin supplement
Vujkovic et al. (2007)(151) Study design: data from I is referred to dietary patterns, not to proper
amounts of micronutrient
Vujkovic et al. (2009)(152) Study design: data from I is referred to dietary patterns, not to proper
amounts of micronutrient
Wald et al. (1996)(153) Irrelevant health outcome
Wright (1995)(154) Study design: case–control
RCT, randomized controlled trial; S, status; H, health; I, intake.
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Mean vitamin B12 intakes were significantly higher in the
omnivorous group (2?9 (SD 1?3)mg/d) in comparison to
the macrobiotic group (0?3 (SD 0?2)mg/d; P, 0?001).
These differences could be also be shown in the scores
obtained in the psychomotor development test in the
areas of gross motor development (for which the mean
difference in standard deviations between feeding groups
was 20?48) and speech and language development
(for which the mean difference in standard deviations
between feeding groups was 20?42), with a P value of
0?04 and 0?03, respectively. Despite these differences in
health outcomes obtained between feeding groups, the
authors did not study an association between vitamin B12
intakes and differences in scores in psychomotor tests; for
this reason, these results cannot be attributed only to the
obtained difference in vitamin B12 intakes.
The results of the four studies evaluating the I-S rela-
tionship showed that the status of vitamin B12 biomarkers
is significantly and positively associated with vitamin B12
consumption (ingested or injected). The strength of this
association was stated in almost all of the studies, with the
exception of one RCT(29) in which the regression coeffi-
cient was not given. The limited availability of I-H data in
infants did not allow for drawing any conclusions.
Children and adolescents
For the children and adolescents group, we identified
four cross-sectional studies(33–35,37) and one RCT(36). Two
out of three cross-sectional studies were conducted with
children(33,37), one study(34) was carried out among adole-
scents and one(35) included both children and adolescents.
In three cross-sectional studies(33–35), vitamin B12 intake and
plasma vitamin B12 was described. However, searching
for an association between intake and status was not the
purpose of the studies. Only in the study by Hay et al.(37),
performed in Norwegian children, was vitamin B12 intake
shown to be significantly and positively associated
(r50?21, P, 0?05) with HoloTC. In that study, serum
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n 5219 references
identified from
database search
n 16 relevant
references for
further analysis
n 101 references
excluded from further
 analysis
n 0 references
identified from
reference lists of
systematic reviews
n 5815 references screened for inclusion based on title and abstract
n 5 relevant references
for children and
adolescents
n 6 relevant references for
pregnant and lactating
women
n 596 references
identified from update
database search 
n 5 relevant references
for infants
n 5625 references
excluded
n 117 potentially relevant
references for inclusion based
on full text
Fig. 2 Selection of studies for the current systematic review
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Table 2 Main characteristics of the studies selected in the systematic review by study population group
Group Study Country
Population
(characteristics, n) Objectives Design Intake Status Health outcome Results Conclusion
Infants Dagnelie
and van
Staveren
(1994)(32)
Netherlands 4–18-month-years old
macrobiotic infants
(n 53) and
omnivorous control
subjects
(n 57) were
assessed in three
cohorts: one
cohort aged
4–10 months, the
second cohort
aged 8–14 months
and the third cohort
aged
12–18 months
To associate
macrobiotic
diets in infants
with lower
scores in
psychomotor
development in
comparison
with
omnivorous
diet infants
Population-based,
mixed-longitudinal
cohort study, in which
omnivorous group was
frequency-matched with
the macrobiotic
group for month
of birth, sex, parity,
education of the
parents and region
of residence
Mean (SD) vitamin
B12 intake
(mg/d) was
significantly
different in the
macrobiotic
group (n 49),
0?3 (SD 0?2),
and the
omnivorous
group (n 57),
2?9 (SD 1?3),
P, 0?001
Plasma vitamin B12
concentrations were
149 pmol/l in macrobiotic
infants and 404 pmol/l
in omnivorous infants
(P, 0?001)
Differences in
psychomotor
development of
macrobiotic infants
relative to
omnivorous infants
(means of differences
in SD): 20?48 for
gross motor
development and
20?42 for speech
and language
development
The psychomotor
checklist
revealed that the
macrobiotic
group was
significantly
slower in gross
motor (P5 0?04)
and in speech
and language
development
(P5 0?03)
The macrobiotic
group had worst
scores regarding
psychomotor
development.
However, no
association with
lower intakes of
vitamin B12 was
looked for
Worthington-
White
et al.
(1994)(29)
USA 184 premature infants
(,1800 g at birth
and ,36 weeks’
gestation)
To investigate if
IM injection of
vitamin B12
has effects on
vitamin B12
biomarkers
Single-centre,
randomized,
placebo-
controlled trial.
Study groups:
folate1vitamin B12
supplementation;
folate only;
vitamin B12
only; and no
additional
supplementation
Control group:
vitamin B12
15mg/l/d
administered
IM10?07 pmol/l
administered
by formula fed
as tolerated.
Supplemented
group: the
same as
control
group1100mg
vitamin B12 IM
per month for
4 months
Mean (SEM) serum
vitamin B12 (pmol/l) in
supplemented groups(29)
was 640 (100) at
baseline, 1150 (130)*
at 1–2 weeks, 990 (110)*
at 3–4 weeks, 830 (100)-
at 6–8 weeks, 910 (150)-
at 10–12 weeks and 1010
(230)- at 6 months. In the
control group(28) the
corresponding amounts
were: 830 (200), 640
(60)-, 500 (60)*, 270 (50)-
-
,
380 (60)- and 810 (180).
*--
-
Significantly different
from values at birth:
*P,0?01; -P,0?05;
-
-
P,0?005
Not stated Not stated In vitamin
B12-supplemented
patients, an
increase in serum
B12 concentrations
was serologically
demonstrated in
comparison with
those who did not
receive any
supplementation
Jones
et al.
(2007)(30)
Guatemala 304 infants
and their
mothers
To examine
predictors of
deficient
plasma
vitamin B12
concentrations
Cross-sectional study.
A door-to-door census
was conducted and SES,
anthropometry, dietary
intake of vitamin B12 and
micronutrient status were
measured at
12 months of age
Estimated mean
intake of vitamin
B12 in mothers
was 3?1mg/d
and 2?2mg/d in
infants using
a semi-
quantitative
FFQ
Mean (SD) plasma
vitamin B12 in infants was
262?2 (163?5) pmol/l and
in mothers 114?4 (9?2) g/l
Not stated Infant intake of
B12 is a predictor
of infant plasma
B12 (r5 0?16,
P, 0?0001;
n 270)
Infant intake from
complementary
foods was
positively
associated with
infant plasma
vitamin B12
Bjorke-
Monsen
et al.
(2008)(28)
Norway 107 healthy,
term, 6-week-old
(62 weeks) infants
To investigate if
IM injection of
vitamin B12
has effects on
vitamin B12
biomarkers
RCT. Intervention
group: n 54; control
group: n 53
An IM injection
of 400mg of
hydroxycobala-
min after blood
sampling at the
first visit
In the intervention group,
median (range) serum
B12 (pmol/l) was 172
(128–250) at 6 weeks and
421 (291–497) at
4 months; median (range)
MMA (pmol/l) was
0?58 (0?28–0?97) at
6 weeks and 0?20
(0?15–0?43) at
4 months
Not stated Regression
coefficient5183
(P,0?001) for
serum vitamin B12
and regression
coefficient5
20?70
(P,0?001) for
MMA, between
injected vitamin
B12 and vitamin
B12 status
At 4 months, vitamin
B12 intervention
was by far the
strongest
predictor of infant
vitamin B12
status
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Hay et al.
(2008)(31)
Norway 364 mothers and their
healthy children
To investigate if
different levels
of intake of
vitamin B12
have effects on
vitamin B12
biomarkers
In a longitudinal study,
serum vitamin B12,
HoloTC and MMA were
measured at birth and at
6, 9, 12, 18 and
24 months
Mean (95 % CI)
daily intake of
vitamin B12 at
12 months,
excluding intake
from breast
milk, in breast-
fed (n 104) and
non-breast-fed
(n 115) infants
was 1?4 (1?3,
1?6)mg and 2?4
(2?1, 2?6)mg,
respectively
(P,0?001),
measured by
using question-
naires and 7 d
weighed-food
records at
12 months
Mean (95 % CI) serum
vitamin B12, HoloTC
and MMA (pmol/l)
were 343 (319, 369;
n 85), 54 (49, 60;
n 78) and 0?22
(0?20, 0?25; n 86),
respectively, for
breast-feeding infants
receiving complementary
foods. Corresponding
values were 397 (372,
424; n 127), 76 (70, 83;
n 117) and 0?20 (0?19,
0?22; n 125) for
non-breast-fed infants at
12 months
Not stated Partial r values
considering total
vitamin B12
intake were 0?15
(P5 0?030) for
serum vitamin
B12 and 0?25
(P5 0?001) for
HoloTC
Vitamin B12 intake
at 12 months was
significantly
associated with
both serum
vitamin B12 and
HoloTC
Children
and
adole-
scents
Papoutsakis
et al.
(2006)(33)
Greece 186 sixth-grade
students
(99 females and
87 males aged
10?8–13?5 years)
To describe the
intake and the
status of
vitamin B12 in
children
Cross-sectional study by
face-to-face interview.
B12 was measured in
plasma and dietary intake
data were collected by
two non-consecutive 24 h
recalls
Mean (95 % CI)
for vitamin B12
intake was 3?2
(2?7, 3?8)mg/d
in females and
3?7 (3?1,
4?5)mg/d in
males
(P50?024)
Mean (95 % CI) for
plasma vitamin B12
(pmol/l) was 411
(388, 435) for females
(n 99) and 383 (360, 406)
for males (n 87)
Not stated Not stated Not stated
Gewa et al.
(2009)(36)
Kenya 520 children (270
boys and 250 girls)
with a mean age of
7?4 years,
belonging to twelve
selected schools
randomized to one
of four feeding
groups during 24
months
To evaluate the
relationship
between
dietary vitamin
B12 and gains
in cognitive
test scores
A 2-year longitudinal,
randomized controlled
feeding intervention study
using animal-source
foods, in which dietary
nutrient values were
obtained from nineteen
24 h recalls (at least
once per month), and a
cognitive battery test
repeated once per term
As there were no
significant
differences
between boys
and girls
regarding
vitamin B12
intakes, mean
intake for the
entire group
was 0?64
(SD 0?38)mg
Not stated As there were no
significant differences
between boys and
girls regarding Digit
span-forward test,
mean (SD) score in
this part of the
cognitive test for the
entire group was
2?79 (1?12)
A child with a
daily high intake
of vitamin B12
gained a
significant 0?24
more points in
the Digit Span-
forward test than
one with a low
intake level
These results
demonstrate the
importance of
improved intake
of vitamin B12
contained in
animal-source
foods on
cognitive function
among school-
aged children
Hay et al.
(2011)(37)
Norway 178 children from
2-year-olds
(68 girls and
87 boys)
To examine
vitamin B12
intake in
relation to
serum vitamin
B12 status in
2-year-olds
Cross-sectional study by
face-to-face interview.
B12 was measured in
plasma and dietary intake
data were collected by
7 d weighed records
(seven consecutive
days). Information on
supplement use was also
taken
Mean vitamin B12
intake without
gender
differences
was 3?1mg/d
Median serum vitamin B12
was 407 pmol/l for the
total population, median
HoloTC was 93 and 106
pmol/l for boys and girls,
and MMA was 0?16 and
0?14mmol/l for boys and
girls, respectively
(significant differences
between boys and girls
for HoloTC and MMA;
n 155)
Not stated Significant
correlation was
found for vitamin
B12 intake and
HoloTC (r5 0?21,
P, 0?05)
HoloTC was more
significantly
associated with
vitamin B12
intake than other
biomarkers
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Steluti et al.
(2011)(34)
Brazil 99 adolescents
(58?6 % were girls)
whose mean age
was 17?6 years
To report
vitamin B12
intakes and
serum
concentrations
in Brazilian
adolescents
Cross-sectional study
by face-to-face
interview. B12 was
measured in plasma
and dietary intake
data were collected
by 3 d records
(three non-consecutive
days)
Mean (95 % CI)
vitamin B12
intake was
4?45 (4?28,
4?64)mg/d
Mean (SD) serum vitamin B12
was 397?5 (188?4) pg/ml
Not stated Not stated Not stated
Yeung et al.
(2011)(35)
USA Non-pregnant
population aged
1–18 years
(n 7161)
To report vitamin
B12 intakes
and serum
concentrations
in US children
and
adolescents
Cross-sectional study.
B12 was measured in
plasma and dietary intake
data by two 24 h recalls
on non-consecutive days
(the first in person and
the second by telephone).
Information on
supplement use was also
taken
Results are
shown by FA
consumption
group and
sociodemo-
graphic
characteristics
Mean serum vitamin B12
(n 5895) and MMA
(n 2436) results are
shown by FA
consumption group and
sociodemographic
characteristics
Not stated Not stated Not stated
Pregnant
and
lactat-
ing
women
Koebnick
et al.
(2002)(39)
Germany 39 healthy pregnant
women
participated in the
study throughout
their pregnancies
until delivery
To describe
ranges of
biochemical
indices of
vitamin B12
status and
vitamin B12
intake in all
trimesters of
uncomplicated
pregnancy
Prospective longitudinal
study in which serum
vitamin B12 and dietary
intake data (using 4 d
food records) were
assessed in weeks 9–12,
20–22 and 36–38. Intake
of supplements was
recorded
Mean (SD) intake
of vitamin B12
from the first to
the third
trimester was
5?6 (2?0)mg/d
Mean (95 % CI) serum B12
(pmol/l): 257 (226–292)
in 1st month(31),
239 (212–268) in
2nd month(39) and
178 (161–198) in
3rd month(38), with
P,0?0001 adjusted for
maternal age
Not stated Not stated The intake of
vitamin B12 did
not correlate with
vitamin B12
concentrations in
blood
Lindblad
et al.
(2005)(40)
Pakistan 46 women and their
IUGR infants as
well as 82 pairs
with normal birth
weight
To investigate
whether IUGR
was
associated
with altered
maternal and
fetal levels of
vitamin B12
Prospective observational
study. Mothers and
fetuses were followed at
least 3–4 times since
week 12 of pregnancy
until the delivery
Not stated Median (range) serum
vitamin B12 (pmol/l) in
mothers: IUGR
96 (23–266), normal
108 (29–317). Median
(range) vitamin B12
(pmol/l) in umbilical cord:
IUGR 190 (61–913),
normal 171 (48–534).
Median (range) maternal
vitamin B12 was
102 (23–317) pmol/l
46 infants were
considered IUGR v.
82 who had normal
birth weight. 21 % of
normal birth weight
infants’ mothers had
pre-eclampsia and
26 % of IUGR
mothers
P values for
maternal
(P5 0?42) or
umbilical cord
(P5 0?24)
vitamin B12 levels
(pmol/l) in
comparison
between IUGR
and normal birth
weight. Birth
weight was not
significantly
different between
mothers with pre-
eclampsia
(P5 0?53)
Neither maternal
nor umbilical cord
vitamin B12 levels
were associated
with IUGR. There
were no
significant
differences
between IUGR
and normal birth
weight infants’
mothers
regarding
pre-eclampsia
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Muthayya
et al.
(2006)(42)
India 478 pregnant
women were
recruited at
12?963?3 weeks’
gestation
To assess
maternal
dietary vitamin
B12 and its
biomarkers in
apparently
healthy
pregnant
women in
order to
determine their
associations
with IUGR
Prospective cohort study.
Information on
sociodemographic factors
at baseline and on
maternal anthropometry,
dietary intake, clinical
status and blood at
baseline, second
trimester of pregnancy
and third trimester of
pregnancy were collected
An FFQ for the
preceding
3 months of
each trimester,
validated
against 24 h
recalls
obtained thrice
for each
trimester, was
assessed for
each pregnant
woman. Mean
intakes of
vitamin B12
were not stated
In a subsample of 185
women, serum vitamin
B12 medians and IQR for
each trimester and for
each tertile were obtained
The incidence of
IUGR babies was
28?6 % (n 108)
AOR55?98, 9?28
and 2?81 in
trimesters 1 to
3, respectively, for
women in the
lowest tertile for
serum B12
concentration
during each of the
trimesters of
pregnancy in
relation to risk of
IUGR. Coefficients
of correlation
between vitamin
B12 intake and
status in all three
trimesters:
trimester 1
(n 135, r50?22,
P50?009);
trimester 2
(n 140, r50?21,
P50?013);
trimester 3
(n 147, r50?20,
P50?017)
Women in the
lowest tertile for
serum B12
concentration
during each of
the trimesters of
pregnancy had
significantly
higher risk of
IUGR
Morkbak
et al.
(2007)(41)
Denmark Apparently healthy
lactating mothers
(n 89) including 23
supplemented with
vitamin B12,
41 partly
supplemented
and 25 not
supplemented
To examine
longitudinal
changes in
serum
cobalamins
during lactation
and to
investigate the
influence of
vitamin B12
supplementa-
tion on these
parameters
A 9-month follow-up study
for three different
statuses of
supplementation
pregnant groups. Blood
samples collected week
3 (baseline) and months
4 and 9 postpartum were
analysed for cobalamins
Median (range)
of B12
supplementa-
tion (mg/d):
1 (0–13?5) at
baseline
(n 89);
1 (0–13?5)
at 4 months
(n 87);
0 (0–18?0) at
9 months
(n 86)
Median (range)
cobalamins (pmol/l):
322 (129–1039) at
baseline (n 89); 317
(114–1247) at 4 months
(n 87); 315 (145–1193) at
9 months (n 86). Median
(range) HoloTC (pmol/l):
85 (30–1068) at basleine
(n 89); 87 (20–1020) at
4 months (n 87);
76 (30–972) at
9 months (n 86)
Not stated P values for
differences in
cobalamin status
between baseline
and 4 months
and between
4 months and
9 months were
not statistically
significant;
P50?02 between
baseline and
4 months and
P50?01 between
4 and 9 months
for HoloTC
The levels of serum
cobalamins and
HoloTC after
9 months showed
no statistical
differences
between the
groups
supplemented or
unsupplemented
at any of three
visits
Baker
et al.
(2009)(38)
UK 500 pregnant
adolescents
(14–18 years) were
recruited from
2 inner-city
populations at
gestational age
#20 weeks
To assess vitamin
B12 intake and
its biomarkers
in pregnant
women and to
determine
associations
with infant
growth
Prospective study.
Three non-consecutive
24 h recalls were
conducted during the
third trimester.
Supplement use was also
recorded
Mean (SD) intake of
vitamin B12 of
290 mothers
was 5?31
(4?96)mg/d;
median (IQR)
was 4?31
(2?97–6?11)
mg/d
In 290 mothers, mean (95 %
CI) serum vitamin B12
(pmol/l) of SGA infants
(n 45) was 188 (166–212)
and 175 (167–184) for
non-SGA (n 245)
17?6 % were SGA
(n 478)
Ratios of geometric
means between
SGA and non-
SGA births were
1?07 (0?94–1?22)
with P50?276 by
simple regression
analysis and
1?10 (0?98–1?23)
with P50?092
by multiple
regression
analysis
Serum vitamin B12
in mothers was
not associated
with SGA infants
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vitamin B12 and MMA were also measured; however, no
association with them was found.
In the RCT by Gewa et al.(36), the targeted population
group was children and the studied relationship was I-H.
The authors discovered that children with a daily high
intake of vitamin B12 gained a significant 0?24 more points
in the Digit Span-forward test (as part of the entire cognitive
test) than others with a low intake level, considering intakes
of vitamin B12 predictors of the Digit Span-forward test.
Pregnant and lactating women
Regarding the pregnant and lactating women group,
six prospective observational studies were included(38–43).
Four of them studied the relationship between status and
health outcomes in the fetus (intra-uterine growth retarda-
tion (IUGR), small for gestational age (SGA) and growth in
general)(38,40,42,43). In Lindblad et al.’s study(40), the results
suggested that in infants with normal birth weight, cord
blood levels of vitamin B12 were correlated with maternal
levels of serum vitamin B12. However these correlations
were weaker when infants had IUGR. In the study by Baker
et al.(38), serum vitamin B12 levels in mothers were not
associated with the risk of SGA infants. However, in
Muthayya et al.’s study(42) women in the lowest tertile for
serum vitamin B12 concentration during each of the trime-
sters of pregnancy had significantly higher risk of delivering
IUGR infants. In this last study, a correlation between
vitamin B12 intake and status was also reported in all three
trimesters. In Takimoto et al.’s study(43), maternal vitamin B12
status, assessed in the third trimester of the pregnancy, was
not associated with gestational weight, weight, length or
head circumference of infants at delivery or at 1 month after
delivery. Two studies(39,41) described longitudinal changes in
vitamin B12 biomarkers through pregnancy, I-S being the
main relationship examined. In one longitudinal study(39),
vitamin B12 intake in pregnant women was not associated
with serum vitamin B12. In the study by Morkbak et al.
(41),
which is the only selected study on pregnant women, in
spite of there being three different supplementation groups,
as there were no significant differences between them,
results were presented for all three groups together. No
change was observed in serum vitamin B12 throughout the
study period, whereas a significant decrease was observed
for HoloTC from baseline to the 9th month.
The observed I-S and S-H relationships were not
consistent and further conclusions cannot be extracted.
Quality of included studies
Table 3 summarizes the method used to assess the quality
of the included studies. Only three studies had a high
risk of bias(29,33,36). Five studies had a moderate risk
of bias(28,31,34,35,38) and eight studies reflect low risk of
bias(30,32,37,39–43). The most repeated reason for risk of
bias across the studies was an inadequate explanation
about the drop-outs and an inadequate assessment of
exposure (method to assess vitamin B12 intakes).
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Discussion
From 5815 identified papers, only sixteen were suitable
to be included in the review according to EURRECA’s
eligibility criteria. From these, five papers focused only on
descriptions of vitamin B12 intakes and biomarkers with-
out any stated association. Because of the small number
of eligible papers included in the review, only a few main
conclusions can be drawn for the specific population
groups studied.
Infants
In this population group, vitamin B12 (ingested or injected)
was significantly and positively associated with vitamin B12
biomarkers. Serum vitamin B12 was investigated in all four
studies. The evidence, however, was not sufficient for
HoloTC (only one study(31)) or MMA (two studies(28,31), while
in one study(31), associations were not found for MMA).
In this population group, the two included interven-
tions were performed through injection of vitamin B12.
Although injection could be a more reliable method
of intervention, in general oral administration is better
tolerated in the absence of neurological problems(44,45).
Moreover, it should be noted that exposure to vitamin B12
via oral supplements or intramuscular injections is very
different as e.g. bioavailability issues are different.
Children and adolescents
Among the four cross-sectional studies(33–35,37) included
in this population group, the only available finding was
the positive association between children’s intake of
vitamin B12 and serum HoloTC in one of them. In that
study, serum vitamin B12 and MMA were also investigated
without any obtained association. The other three cross-
sectional studies did not look for any association.
In the RCT of Gewa et al.(36), it was demonstrated that
higher vitamin B12 intakes are associated with higher
scores in one part of a cognitive test. However, only one
study represents very limited data from which to extract a
clear conclusion and in this respect, drawing conclusions
may not be justified.
Pregnant and lactating women
Regarding the S-H relationships searched for in this
group, as well as for I-S ones, no conclusions can be
drawn due to the discrepancies in the results. One
study(42) showed an association between status and fetal
growth and three(38,40,43) showed no association. On the
other hand, due to the heterogeneity shown in results
regarding I-S relationships in all five included studies, it is
possible to conclude that intake of vitamin B12 in preg-
nant and lactating women is not related to vitamin B12
concentration in their blood. This fact can be derived
from the vitamin B12 gradient in the placenta, between the
fetus and the mother. During pregnancy, vitamin B12 had
been noted to decrease in mothers but not its transport
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molecules. Such an observation of the placenta facilitating
the transport of a critical nutrient (as occurs with vitamin B12)
for fetal growth and development when the mother is
deficient is another revelation of how important the placenta
is in maintaining the development of the fetus(46,47). In the
other four studies(38–41) there were no significant or relevant
associations present.
Use of biomarkers in studies
One of the currently open questions regarding vitamin B12
is to determine the best biomarker to assess its
status. In the present review, data were insufficient to draw
conclusions about the effectiveness of serum HoloTC or
MMA as a biomarker of vitamin B12 status (only one study
showed a positive association between vitamin B12 intakes
and HoloTC in children(37)). However, MMA and HoloTC
are more sensitive markers for vitamin B12 deficiency than
plasma vitamin B12
(48) by reflecting sudden changes in
vitamin B12 homeostasis, whereas plasma vitamin B12
seems to reflect the accumulation of vitamin B12
(49). On the
other hand, they are extremely variable in these periods of
life, making difficult their interpretation(31). Moreover, due
to the ability of serum/plasma vitamin B12 to describe the
status of vitamin B12 through time, without being influ-
enced by punctual intake, serum/plasma vitamin B12 is the
most common biomarker to assess vitamin B12 status.
Cognitive function
One of the constraints to the lack of data in the research
on vitamin B12 intake and cognitive function is that even
detailed examinations are not sufficiently accurate to
detect developmental delays in young infants. However,
reports on short- and long-term neurological effects
related to vitamin B12 deficiency in young infants
demonstrate the importance of an adequate vitamin B12
status during the first months of life(28). Vitamin B12 is also
suggested to be related with neurocognitive function in
school-aged children(50). In the present systematic
review, two papers on this topic suggested this asso-
ciation (one in infants, the other in children). However, in
the infants study(32), the differences in scores in psycho-
motor tests were associated with type of diet (macrobiotic
or omnivorous) and not with intake of vitamin B12
(however, the authors found significant differences in
vitamin B12 intakes between diet groups).
Megaloblastic anaemia
Although being selected as a relevant health outcome for
infants and children and adolescents, no paper on
megaloblastic anaemia was finally included. However,
some bibliography has reported megaloblastic anaemia
as a typical symptom of vitamin B12 deficiency, usually
as a consequence of previous maternal vitamin B12 defi-
ciency(51). Absence of included studies investigating this
outcome suggests the low quality of reporting of the
available studies, which were mostly old case reports.
No studies were found for megaloblastic anaemia in
pregnant and lactating women. The explanation for no
revealed hits could be that the literature about megalo-
blastic anaemia in this vulnerable group is linked mostly
to intake and status of folate rather than the intake and
status of vitamin B12
(52).
Growth
Of four papers focusing on fetal/infant growth (SGA,
IUGR or general growth) in pregnant and lactating
women, as only one has shown a positive association, no
clear conclusion can be extracted in this regard.
Fetal malformations
The literature reveals that neural tube defects are the
most common fetal malformation linked to deficiency of
vitamin B12 in mothers
(53). However, due to the strict
inclusion criteria of the present systematic review, no
studies on this topic were included.
Maternal pre-eclampsia
This health outcome was mentioned in only one of the
longitudinal studies in the pregnant and lactating women
group. However, there was no significant difference in
vitamin B12 status among mothers who suffered pre-
eclampsia compared with mothers without pre-eclampsia(40).
In another similar study, no significant differences were
observed in both maternal and fetal serum vitamin B12
between a severe pre-eclampsia group v. mild pre-eclampsia
and control groups(54).
Conclusions
The current systematic review emphasizes a number of
knowledge gaps in the field of vitamin B12 research for
young populations and pregnant and lactating women,
derived from the scarcity and the low quality of available
studies.
One of the reasons for this scarce literature on vitamin B12
in young population groups could be that mild vitamin B12
deficiency is more prevalent among elderly people in
association with a number of chronic diseases(55).
There is also evidence that vitamin B12 deficiency is
uncommon in young populations, unless they belong to a
vegan community, or live in a developing area, or have
a congenital malabsorption syndrome(56). However, the
prevalence in younger groups may be higher than for-
merly recognized(57).
RCT with enough power and varying doses of dietary
intakes and duration of supplementation are required in
order to establish vitamin B12 recommendations for young
populations. Further studies to correlate serum/plasma
vitamin B12, MMA and HoloTC and also to explore vitamin B12
adequacy in young age groups are needed.
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